Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi

NACompletedINTERVENTIONAL
Enrollment

498

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Malaria, Falciparum
Interventions
DRUG

Artemether-lumefantrine combination

Dispersible formulation of artemether-lumefantrine at a dose of 2/12 mg/kg body weight of artemether and lumefantrine, respectively, per dose, given twice a day for 3 days

DRUG

Artesunate-amodiaquine combination

Co-formulated artesunate-amodiaquine at a dose of 4 mg/kg/day artesunate and 10 mg/kg/day amodiaquine once a day for 3 days

DRUG

Dihydroartemisinin-piperaquine

Co-formulated dihydroartemisinin-piperaquine at a dose of 4 mg/kg/day dihydroartemisinin and 18 mg/kg/day piperaquine once a day for 3 days

Trial Locations (1)

Unknown

Machinga District Hospital, Liwonde

All Listed Sponsors
collaborator

Kamuzu University of Health Sciences

OTHER

lead

Centers for Disease Control and Prevention

FED

NCT01326754 - Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi | Biotech Hunter | Biotech Hunter